Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACC Annual Scientific Session In Brief

This article was originally published in The Gray Sheet

Executive Summary

COMPASS-HF: Remote monitoring with Medtronic's investigational Chronicle implantable hemodynamic monitor (IHM) is associated with 41% fewer heart-failure related hospitalizations compared with optimal medical management alone in the 274-patient, 28-center randomized COMPASS-HF (Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure) study. Enrollees had NYHA Class III or IV heart failure and made at least one heart failure-related hospital trip in the last six months. Robert Bourge, MD, University of Alabama-Birmingham, presented the study results at the American College of Cardiology Annual Scientific Session in Orlando March 8...
Advertisement

Related Content

Cardiology News In Brief
Cardiology News In Brief
CRT-D May Reap Higher CE Ratio Than Defibrillation Alone – Annals Editorial
CRT-D May Reap Higher CE Ratio Than Defibrillation Alone – Annals Editorial
CRT-P Versus CRT-D: A Match-Up Likely Never To Be Seen – NEJM Editoral
CRT-P Versus CRT-D: A Match-Up Likely Never To Be Seen – NEJM Editoral
FilterWire Embolic Protection May Be Effective In Patients With AMI – JAMA
Vasomedical Gains CHF Indication For Noninvasive Counterpulsation Therapy
Vasomedical Gains CHF Indication For Noninvasive Counterpulsation Therapy
Advertisement
UsernamePublicRestriction

Register

MT021750

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel